Department of Physiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Laboratory Expert Department of Physiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Metab Brain Dis. 2021 Oct;36(7):2089-2100. doi: 10.1007/s11011-021-00795-4. Epub 2021 Aug 6.
Parkinson's disease (PD) is a complex neurodegenerative disease in which the understanding of the underlying molecular mechanisms can be constructive in the diagnosis and treatment. Matrix metalloproteinase (MMPs) elevation and damage to the blood-brain barrier (BBB) are critical mechanisms involved in the PD separation. Studies have revealed that changes in miR-149-5p and CoQ10 are associated with BBB damage, and CoQ10 can affect the levels of some miRs. Hence, in the present study, we aimed to evaluate CoQ10 and miR-149-5p mimic on miR-149-5p, MMPs and TH expression, and behavioral functions of the PD models. PD was induced by injection of 6-OHDA into the rats' Medial Forbrain Bundle (MFB). The behavioral tests, including the Rotation test, Rotarod test, and Open field test, have been directed two weeks after PD induction. Next, the MiR-149-5p mimic (miR-mimic) and CoQ10 have been administered to rats. The same behavioral tests have been evaluated two weeks after administration to investigate the effect of miR-149-5p mimic and CoQ10. The rats were followed extra four weeks, and the behavioral tests have performed again. Finally, the expression of MMPs and miR-149-5p genes was measured using RT-qPCR, and tyrosine hydroxylase (TH) was assessed through immunohistochemistry analysis. According to the obtained results, the level of miR-149-5p has decreased, followed by PD induction in rats. RT-qPCR analysis has represented upregulation and downregulation of miR-149-5p and MMP-2,9, respectively, after miR-mimic and CoQ10 treatment. The treated rats have also represented improved motor function and increased TH + cells in the striatum according to the behavioral tests and immunohistochemistry assay. Taking together miR-149 and CoQ10 has shown to have an impressive potential to prevent damage to dopaminergic neurons caused by 6-OHDA injection through reducing MMP-2,9, increased TH expression, and improved motor function.
帕金森病(PD)是一种复杂的神经退行性疾病,深入了解其潜在的分子机制有助于进行诊断和治疗。基质金属蛋白酶(MMPs)的升高和血脑屏障(BBB)的损伤是 PD 发病机制中的关键机制。研究表明,miR-149-5p 和 CoQ10 的变化与 BBB 损伤有关,而 CoQ10 可以影响一些 miRs 的水平。因此,在本研究中,我们旨在评估 CoQ10 和 miR-149-5p 模拟物对 PD 模型中 miR-149-5p、MMPs 和 TH 表达及行为功能的影响。通过向大鼠中脑内侧束(MFB)注射 6-OHDA 诱导 PD。在 PD 诱导后两周进行旋转试验、旋转棒试验和旷场试验等行为学测试。然后,给予大鼠 miR-149-5p 模拟物(miR-mimic)和 CoQ10。给药两周后,进行相同的行为学测试,以研究 miR-149-5p 模拟物和 CoQ10 的作用。额外四周后,对大鼠进行行为学测试。最后,通过 RT-qPCR 测量 MMPs 和 miR-149-5p 基因的表达,通过免疫组织化学分析评估酪氨酸羟化酶(TH)。根据获得的结果,miR-149-5p 的水平在大鼠 PD 诱导后降低。RT-qPCR 分析表明,miR-mimic 和 CoQ10 处理后,miR-149-5p 和 MMP-2、9 的表达分别上调和下调。行为学测试和免疫组织化学检测结果表明,治疗组大鼠运动功能改善,纹状体中 TH+细胞增多。综上所述,miR-149 和 CoQ10 通过减少 MMP-2、9,增加 TH 表达和改善运动功能,显示出预防 6-OHDA 注射引起的多巴胺能神经元损伤的巨大潜力。